» Articles » PMID: 11180172

Increase of RM3/1-positive Macrophages in Radiation-induced Oral Mucositis

Overview
Journal J Pathol
Specialty Pathology
Date 2001 Feb 17
PMID 11180172
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to describe the distribution patterns of various leukocyte subpopulations in the oral mucosa during the course of radiotherapy and to determine whether there are dose-dependent alterations, or any correlation between the clinical stages and the population density of specific leukocytes. The distribution and density of various leukocytes in oral mucosa in 13 head and neck cancer patients were immunohistochemically analysed before radiotherapy at 30 and 60 Gy and compared with the clinical degree of oral mucositis. Antibodies were used which characterized different subtypes of macrophages (27E10, 25F9, RM3/1) and recognized epitopes of granulocytes (CD15) and T cells (CD3, CD4, CD8). The study showed that whereas macrophages reactive with RM3/1 increased significantly at 30 Gy (p<0.01) and showed a further increase at 60 Gy (p<0.01), no significant alterations could be detected in the density of macrophages which stained positively for 27E10 or 25F9. Moreover, the percentage of macrophages reactive with RM3/1 showed a non-linear correlation with the clinical mucositis score (p<0.05). No significant alterations were detected in the percentage of T cells and granulocytes, compared with the values before radiotherapy. In conclusion, radiation-induced mucositis is characterized by features of an intermediate stage of an inflammatory response, suggesting active involvement of down-regulatory macrophages in its pathogenesis.

Citing Articles

Predictive Factors for Esophageal Stricture Following Definitive Chemoradiotherapy in Esophageal Carcinoma.

Krishna S, Muzumder S, Johnson S, Srikantia N, U A, Ghosh S J Gastrointest Cancer. 2025; 56(1):65.

PMID: 39953181 DOI: 10.1007/s12029-025-01192-1.


Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer.

Nakayama Y, Ando T, Takagi H, Motoo I, Ueda Y, Sakumura M J Clin Med. 2024; 13(16).

PMID: 39200948 PMC: 11355245. DOI: 10.3390/jcm13164806.


Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.

Kim J, Kim T, Kim J, Lee I World J Gastroenterol. 2018; 24(7):862-869.

PMID: 29467556 PMC: 5807944. DOI: 10.3748/wjg.v24.i7.862.


Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma.

Marcussen M, Sonderkaer M, Bodker J, Andersen M, Nielsen S, Vesteghem C PLoS One. 2018; 13(1):e0190709.

PMID: 29338018 PMC: 5770028. DOI: 10.1371/journal.pone.0190709.


Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis.

Normando A, Rocha C, de Toledo I, Figueiredo P, Reis P, De Luca Canto G Support Care Cancer. 2017; 25(9):2969-2988.

PMID: 28623401 DOI: 10.1007/s00520-017-3783-8.